By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Tris Pharma, Inc. 

South Brunswick  New Jersey    U.S.A.
Phone: n/a Fax:




Company News
Tris Pharma, Inc. Selected As An Award Winner In The New Jersey Business & Industry Association's 2014 Awards For Excellence 8/27/2014 8:32:05 AM
Vernalis PLC (VNLPY.PK) And Tris Pharma, Inc. Release: Submission Of Tuzistra™ XR (CCP-01) NDA To FDA 6/30/2014 9:15:29 AM
Tris Pharma, Inc. Expands R&D Team With Addition Of Chief Medical Officer And Vice President Of Regulatory Affairs 6/26/2014 7:08:55 AM
Tris Pharma, Inc. Announces Management Changes 4/1/2014 6:37:12 AM
Tris Pharma, Inc. and FSC Laboratories Sign Definitive Commercialization Agreement for Karbinal™ ER (carbinoxamine maleate) Extended-Release Oral Suspension 9/4/2013 10:00:38 AM
Tris Pharma, Inc.'s Generic Pharmaceuticals Business Launches Dextroamphetamine Sulfate Oral Solution 7/10/2013 9:28:45 AM
Tris Pharma, Inc. Hires President for Generic Pharmaceuticals Business 6/20/2013 6:40:14 AM
Tris Pharma, Inc.'s Ketan Mehta Among Ernst & Young LLP Entrepreneur of the Year® 2013 Finalists in New Jersey 5/2/2013 10:10:16 AM
FDA Approves Tris Pharma, Inc.'s Karbinal™ ER 4/3/2013 8:31:29 AM
First Product in Tris Pharma, Inc.'s Collaboration With Vernalis PLC (VNLPY.PK) Achieves Proof-of-Concept, Triggering Milestone Payment to Tris 3/12/2013 9:32:47 AM